PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Comparison by end-user • Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022 • Academic and research institutes – Market size and forecast 2017-2022 • CROs – Market size and forecast 2017-2022 • Market opportunity by end-user PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • High demand for biopharmaceuticals • Growing initiatives for molecular research activities • Increasing importance of promotional activities PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bio-Rad Laboratories • Eppendorf • Harvard Bioscience • Lonza • Thermo Fisher Scientific PART 15: APPENDIX • List of abbreviations     Exhibit 01: Parent market Exhibit 02: Global transfection technologies market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global electroporation instruments market – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global electroporation instruments market – Year over year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Customer landscape Exhibit 19: Global electroporation instruments market by end-user – Market share 2017-2022 (%) Exhibit 20: Comparison by end-user Exhibit 21: Global electroporation instruments market by pharmaceutical and biotechnology companies – Market size and forecast 2017-2022 ($ mn) Exhibit 22: Global electroporation instruments market by pharmaceutical and biotechnology companies – Year over year growth 2018-2022 (%) Exhibit 23: Global electroporation instruments market by academic and research institutes – Market size and forecast 2017-2022 ($ mn) Exhibit 24: Global electroporation instruments market by academic and research institutes – Year over year growth 2018-2022 (%) Exhibit 25: Global electroporation instruments market by CROs – Market size and forecast 2017-2022 ($ mn) Exhibit 26: Global electroporation instruments market by CROs – Year over year growth 2018-2022 (%) Exhibit 27: Market opportunity by end-user Exhibit 28: Global electroporation instruments market by region – Market share 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Electroporation instruments market in Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Electroporation instruments market in Americas – Year over year growth 2018-2022 (%) Exhibit 32: Top 3 countries in Americas Exhibit 33: Electroporation instruments market in EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 34: Electroporation instruments market in EMEA – Year over year growth 2018-2022 (%) Exhibit 35: Top 3 countries in EMEA Exhibit 36: Electroporation instruments market in APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 37: Electroporation instruments market in APAC – Year over year growth 2018-2022 (%) Exhibit 38: Top 3 countries in APAC Exhibit 39: Market opportunity Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Bio-Rad Laboratories overview Exhibit 46: Bio-Rad Laboratories – Business segments Exhibit 47: Bio-Rad Laboratories – Organizational developments Exhibit 48: Bio-Rad Laboratories – Geographic focus Exhibit 49: Bio-Rad Laboratories – Segment focus Exhibit 50: Bio-Rad Laboratories – Key offerings Exhibit 51: Eppendorf overview Exhibit 52: Eppendorf – Product segments Exhibit 53: Eppendorf – Organizational developments Exhibit 54: Eppendorf – Geographic focus Exhibit 55: Eppendorf – Segment focus Exhibit 56: Eppendorf – Key offerings Exhibit 57: Harvard Bioscience overview Exhibit 58: Harvard Bioscience – Organizational developments Exhibit 59: Harvard Bioscience – Geographic focus Exhibit 60: Harvard Bioscience – Key offerings Exhibit 61: Lonza overview Exhibit 62: Lonza – Business segments Exhibit 63: Lonza – Organizational developments Exhibit 64: Lonza – Geographic focus Exhibit 65: Lonza – Segment focus Exhibit 66: Lonza – Key offerings Exhibit 67: Thermo Fisher Scientific overview Exhibit 68: Thermo Fisher Scientific – Business segments Exhibit 69: Thermo Fisher Scientific – Organizational developments Exhibit 70: Thermo Fisher Scientific – Geographic focus Exhibit 71: Thermo Fisher Scientific – Segment focus Exhibit 72: Thermo Fisher Scientific – Key offerings

Bio-Rad Laboratories Eppendorf Harvard Bioscience Lonza Thermo Fisher Scientific